GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » Asset Turnover

Sinopharm Tech Holdings (HKSE:08156) Asset Turnover : 0.00 (As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Sinopharm Tech Holdings's Revenue for the three months ended in Dec. 2024 was HK$0.00 Mil. Sinopharm Tech Holdings's Total Assets for the quarter that ended in Dec. 2024 was HK$44.59 Mil. Therefore, Sinopharm Tech Holdings's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Sinopharm Tech Holdings's annualized ROE % for the quarter that ended in Dec. 2024 was 0.00%. It is also linked to ROA % through Du Pont Formula. Sinopharm Tech Holdings's annualized ROA % for the quarter that ended in Dec. 2024 was 0.00%.


Sinopharm Tech Holdings Asset Turnover Historical Data

The historical data trend for Sinopharm Tech Holdings's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings Asset Turnover Chart

Sinopharm Tech Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 0.48 0.39 0.78 1.06

Sinopharm Tech Holdings Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.12 0.32 - -

Competitive Comparison of Sinopharm Tech Holdings's Asset Turnover

For the Software - Application subindustry, Sinopharm Tech Holdings's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Tech Holdings's Asset Turnover Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's Asset Turnover falls into.


;
;

Sinopharm Tech Holdings Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Sinopharm Tech Holdings's Asset Turnover for the fiscal year that ended in Jun. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jun. 2024 )/( (Total Assets (A: Jun. 2023 )+Total Assets (A: Jun. 2024 ))/ count )
=41.277/( (33.482+44.49)/ 2 )
=41.277/38.986
=1.06

Sinopharm Tech Holdings's Asset Turnover for the quarter that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0/( (44.49+44.682)/ 2 )
=0/44.586
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Sinopharm Tech Holdings  (HKSE:08156) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Sinopharm Tech Holdings's annulized ROE % for the quarter that ended in Dec. 2024 is

ROE %**(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=0/-106.6995
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(0 / 0)*(0 / 44.586)*(44.586/ -106.6995)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-0.4179
=ROA %*Equity Multiplier
=0.00 %*-0.4179
=0.00 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Sinopharm Tech Holdings's annulized ROA % for the quarter that ended in Dec. 2024 is

ROA %(Q: Dec. 2024 )
=Net Income/Total Assets
=0/44.586
=(Net Income / Revenue)*(Revenue / Total Assets)
=(0 / 0)*(0 / 44.586)
=Net Margin %*Asset Turnover
= %*0
=0.00 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Sinopharm Tech Holdings Asset Turnover Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18th Floor, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Internet Plus services; Supply chain services; and Manufacturing and distribution of personal protective equipment. It generates maximum revenue from Supply chain services segment, which includes provision of supply chain management, data analysis and related services and trading of related goods, and trading of medial and related products. Geographically, it derives a majority of revenue from Hong Kong.
Executives
Chiu Sin Nang Kenny 2201 Interest of corporation controlled by you
Creative Big Limited 2101 Beneficial owner
Integrated Asset Management (asia) Limited 2101 Beneficial owner
Yam Tak Cheung 2201 Interest of corporation controlled by you
Quantum Worldwide Investment Limited 2101 Beneficial owner
Best Frontier Investments Limited
Chan Kin Ho Philip 2201 Interest of corporation controlled by you
Lam Yui Keung 2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited 2101 Beneficial owner
Main Key Investments Limited 2201 Interest of corporation controlled by you
Guo Lei 2201 Interest of corporation controlled by you
Chan Tung Mei 2202 Interest of your spouse
Cheung Kwai Lan 2201 Interest of corporation controlled by you
Tse Siu Hoi 2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.) 2102 Investment manager

Sinopharm Tech Holdings Headlines

No Headlines